Tokyo Tape
Sign in
← Otsuka Holdings

Quarterly report · Q3

4578.TEDINET S100PGE4
Period2022-01-01 → 2022-09-30
Filed2022-11-02
StandardIFRS
ConsolidatedYes
Data checks16 of 16 passed
Key figures · 61
MetricValuePeriodScopeSource row
Revenue¥1.27T2022-01-01 → 2022-09-30Cons.Revenue IFRS
Revenue¥451.8bn2022-07-01 → 2022-09-30dCons.Revenue IFRS
Revenue¥1.50T2021-01-01 → 2021-12-31Cons.Revenue IFRS (5-year summary)
Revenue¥1.11T2021-01-01 → 2021-09-30Cons.Revenue IFRS
Revenue¥388.6bn2021-07-01 → 2021-09-30dCons.Revenue IFRS
Operating income¥114.8bn2022-01-01 → 2022-09-30Cons.Operating profit loss IFRS
Operating income¥47.7bn2022-07-01 → 2022-09-30dCons.Operating profit loss IFRS
Operating income¥158.1bn2021-01-01 → 2021-09-30Cons.Operating profit loss IFRS
Operating income¥47.0bn2021-07-01 → 2021-09-30dCons.Operating profit loss IFRS
Profit before tax¥146.0bn2022-01-01 → 2022-09-30Cons.Profit loss before tax IFRS
Profit before tax¥53.2bn2022-07-01 → 2022-09-30dCons.Profit loss before tax IFRS
Profit before tax¥163.6bn2021-01-01 → 2021-12-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥166.3bn2021-01-01 → 2021-09-30Cons.Profit loss before tax IFRS
Profit before tax¥47.1bn2021-07-01 → 2021-09-30dCons.Profit loss before tax IFRS
Net income (owners)¥111.0bn2022-01-01 → 2022-09-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥41.3bn2022-07-01 → 2022-09-30dCons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥125.5bn2021-01-01 → 2021-12-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥126.6bn2021-01-01 → 2021-09-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥35.2bn2021-07-01 → 2021-09-30dCons.Profit loss attributable to owners of parent IFRS
Net income¥113.9bn2022-01-01 → 2022-09-30Cons.Profit loss IFRS
Net income¥42.4bn2022-07-01 → 2022-09-30dCons.Profit loss IFRS
Net income¥130.0bn2021-01-01 → 2021-09-30Cons.Profit loss IFRS
Net income¥36.3bn2021-07-01 → 2021-09-30dCons.Profit loss IFRS
Total assets¥3.19Tat 2022-09-30Cons.Assets IFRS
Total assets¥2.82Tat 2021-12-31Cons.Assets IFRS
Total assets¥2.82Tat 2021-09-30Cons.Total assets IFRS (5-year summary)
Total liabilities¥853.3bnat 2022-09-30Cons.Liabilities IFRS
Total liabilities¥775.7bnat 2021-12-31Cons.Liabilities IFRS
Net assets / equity¥2.33Tat 2022-09-30Cons.Equity IFRS
Net assets / equity¥2.05Tat 2021-12-31Cons.Equity IFRS
Net assets / equity¥2.02Tat 2021-09-30Cons.Equity IFRS
Net assets / equity¥1.88Tat 2020-12-31dCons.Equity IFRS
Equity (owners)¥2.30Tat 2022-09-30Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥2.01Tat 2021-12-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥1.98Tat 2021-09-30Cons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥477.3bnat 2022-09-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥410.7bnat 2021-12-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥448.7bnat 2021-09-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥356.9bnat 2020-12-31dCons.Cash and cash equivalents IFRS
Operating cash flow¥171.1bn2022-01-01 → 2022-09-30Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥228.9bn2021-01-01 → 2021-12-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥197.2bn2021-01-01 → 2021-09-30Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥60.4bn2022-01-01 → 2022-09-30Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥95.3bn2021-01-01 → 2021-12-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥33.0bn2021-01-01 → 2021-09-30Cons.Net cash provided by used in investing activities IFRS
Financing cash flow−¥84.0bn2022-01-01 → 2022-09-30Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥95.8bn2021-01-01 → 2021-12-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥83.7bn2021-01-01 → 2021-09-30Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥204.652022-01-01 → 2022-09-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥76.062022-07-01 → 2022-09-30dCons.Basic earnings loss per share IFRS
EPS (basic)¥231.322021-01-01 → 2021-12-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥233.52021-01-01 → 2021-09-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥64.972021-07-01 → 2021-09-30dCons.Basic earnings loss per share IFRS
EPS (diluted)¥204.632022-01-01 → 2022-09-30Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥76.042022-07-01 → 2022-09-30dCons.Diluted earnings loss per share IFRS
EPS (diluted)¥231.152021-01-01 → 2021-12-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥233.342021-01-01 → 2021-09-30Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥64.82021-07-01 → 2021-09-30dCons.Diluted earnings loss per share IFRS
Equity ratio72.1%at 2022-09-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio71.3%at 2021-12-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio70.5%at 2021-09-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 88
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-01-01 → 2022-09-30¥126.1bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-07-01 → 2022-09-30¥43.4bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2022-01-01 → 2022-09-30¥94.2bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2022-07-01 → 2022-09-30¥31.6bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2022-01-01 → 2022-09-30¥31.9bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2022-07-01 → 2022-09-30¥11.8bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-01-01 → 2022-09-30¥9.9bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-07-01 → 2022-09-30¥2.0bn
Reconciling Itemsreconcilingrevenue2022-01-01 → 2022-09-30−¥32.0bn
Reconciling Itemsreconcilingrevenue2022-07-01 → 2022-09-30−¥11.9bn
Reconciling Itemsreconcilingrevenue intersegment2022-01-01 → 2022-09-30−¥32.0bn
Reconciling Itemsreconcilingrevenue intersegment2022-07-01 → 2022-09-30−¥11.9bn
Reconciling Itemsreconcilingsegment profit2022-01-01 → 2022-09-30−¥34.8bn
Reconciling Itemsreconcilingsegment profit2022-07-01 → 2022-09-30−¥12.0bn
jpcrp040300-q3r_E21183-000Consumer Productsreportable segmentrevenue2022-01-01 → 2022-09-30¥27.0bn
jpcrp040300-q3r_E21183-000Consumer Productsreportable segmentrevenue2022-07-01 → 2022-09-30¥10.3bn
jpcrp040300-q3r_E21183-000Consumer Productsreportable segmentrevenue external2022-01-01 → 2022-09-30¥27.0bn
jpcrp040300-q3r_E21183-000Consumer Productsreportable segmentrevenue external2022-07-01 → 2022-09-30¥10.3bn
jpcrp040300-q3r_E21183-000Consumer Productsreportable segmentrevenue intersegment2022-01-01 → 2022-09-30¥18m
jpcrp040300-q3r_E21183-000Consumer Productsreportable segmentrevenue intersegment2022-07-01 → 2022-09-30¥12m
jpcrp040300-q3r_E21183-000Consumer Productsreportable segmentsegment profit2022-01-01 → 2022-09-30¥5.6bn
jpcrp040300-q3r_E21183-000Consumer Productsreportable segmentsegment profit2022-07-01 → 2022-09-30¥3.8bn
jpcrp040300-q3r_E21183-000Nutraceuticalsreportable segmentrevenue2022-01-01 → 2022-09-30¥325.6bn
jpcrp040300-q3r_E21183-000Nutraceuticalsreportable segmentrevenue2022-07-01 → 2022-09-30¥119.9bn
jpcrp040300-q3r_E21183-000Nutraceuticalsreportable segmentrevenue external2022-01-01 → 2022-09-30¥325.6bn
jpcrp040300-q3r_E21183-000Nutraceuticalsreportable segmentrevenue external2022-07-01 → 2022-09-30¥119.9bn
jpcrp040300-q3r_E21183-000Nutraceuticalsreportable segmentrevenue intersegment2022-01-01 → 2022-09-30¥18m
jpcrp040300-q3r_E21183-000Nutraceuticalsreportable segmentrevenue intersegment2022-07-01 → 2022-09-30¥7m
jpcrp040300-q3r_E21183-000Nutraceuticalsreportable segmentsegment profit2022-01-01 → 2022-09-30¥49.8bn
jpcrp040300-q3r_E21183-000Nutraceuticalsreportable segmentsegment profit2022-07-01 → 2022-09-30¥21.6bn
jpcrp040300-q3r_E21183-000Pharmaceuticalsreportable segmentrevenue2022-01-01 → 2022-09-30¥819.3bn
jpcrp040300-q3r_E21183-000Pharmaceuticalsreportable segmentrevenue2022-07-01 → 2022-09-30¥290.0bn
jpcrp040300-q3r_E21183-000Pharmaceuticalsreportable segmentrevenue external2022-01-01 → 2022-09-30¥819.3bn
jpcrp040300-q3r_E21183-000Pharmaceuticalsreportable segmentrevenue external2022-07-01 → 2022-09-30¥290.0bn
jpcrp040300-q3r_E21183-000Pharmaceuticalsreportable segmentsegment profit2022-01-01 → 2022-09-30¥84.5bn
jpcrp040300-q3r_E21183-000Pharmaceuticalsreportable segmentsegment profit2022-07-01 → 2022-09-30¥32.3bn
—segment totalrevenue2022-01-01 → 2022-09-30¥1.30T
—segment totalrevenue2022-07-01 → 2022-09-30¥463.7bn
—segment totalrevenue external2022-01-01 → 2022-09-30¥1.27T
—segment totalrevenue external2022-07-01 → 2022-09-30¥451.8bn
—segment totalrevenue intersegment2022-01-01 → 2022-09-30¥32.0bn
—segment totalrevenue intersegment2022-07-01 → 2022-09-30¥11.9bn
—segment totalsegment profit2022-01-01 → 2022-09-30¥149.7bn
—segment totalsegment profit2022-07-01 → 2022-09-30¥59.7bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2021-01-01 → 2021-09-30¥110.8bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2021-07-01 → 2021-09-30¥36.9bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2021-01-01 → 2021-09-30¥82.3bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2021-07-01 → 2021-09-30¥26.5bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2021-01-01 → 2021-09-30¥28.4bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2021-07-01 → 2021-09-30¥10.4bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2021-01-01 → 2021-09-30¥12.2bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2021-07-01 → 2021-09-30¥2.8bn
Reconciling Itemsreconcilingrevenue2021-01-01 → 2021-09-30−¥28.5bn
Reconciling Itemsreconcilingrevenue2021-07-01 → 2021-09-30−¥10.4bn
Reconciling Itemsreconcilingrevenue intersegment2021-01-01 → 2021-09-30−¥28.5bn
Reconciling Itemsreconcilingrevenue intersegment2021-07-01 → 2021-09-30−¥10.4bn
Reconciling Itemsreconcilingsegment profit2021-01-01 → 2021-09-30−¥33.6bn
Reconciling Itemsreconcilingsegment profit2021-07-01 → 2021-09-30−¥11.8bn
jpcrp040300-q3r_E21183-000Consumer Productsreportable segmentrevenue2021-01-01 → 2021-09-30¥24.1bn
jpcrp040300-q3r_E21183-000Consumer Productsreportable segmentrevenue2021-07-01 → 2021-09-30¥8.9bn
jpcrp040300-q3r_E21183-000Consumer Productsreportable segmentrevenue external2021-01-01 → 2021-09-30¥24.1bn
jpcrp040300-q3r_E21183-000Consumer Productsreportable segmentrevenue external2021-07-01 → 2021-09-30¥8.9bn
jpcrp040300-q3r_E21183-000Consumer Productsreportable segmentrevenue intersegment2021-01-01 → 2021-09-30¥17m
jpcrp040300-q3r_E21183-000Consumer Productsreportable segmentrevenue intersegment2021-07-01 → 2021-09-30¥8m
jpcrp040300-q3r_E21183-000Consumer Productsreportable segmentsegment profit2021-01-01 → 2021-09-30¥5.8bn
jpcrp040300-q3r_E21183-000Consumer Productsreportable segmentsegment profit2021-07-01 → 2021-09-30¥2.5bn
jpcrp040300-q3r_E21183-000Nutraceuticalsreportable segmentrevenue2021-01-01 → 2021-09-30¥280.1bn
jpcrp040300-q3r_E21183-000Nutraceuticalsreportable segmentrevenue2021-07-01 → 2021-09-30¥104.8bn
jpcrp040300-q3r_E21183-000Nutraceuticalsreportable segmentrevenue external2021-01-01 → 2021-09-30¥280.0bn
jpcrp040300-q3r_E21183-000Nutraceuticalsreportable segmentrevenue external2021-07-01 → 2021-09-30¥104.7bn
jpcrp040300-q3r_E21183-000Nutraceuticalsreportable segmentrevenue intersegment2021-01-01 → 2021-09-30¥33m
jpcrp040300-q3r_E21183-000Nutraceuticalsreportable segmentrevenue intersegment2021-07-01 → 2021-09-30¥12m
jpcrp040300-q3r_E21183-000Nutraceuticalsreportable segmentsegment profit2021-01-01 → 2021-09-30¥45.8bn
jpcrp040300-q3r_E21183-000Nutraceuticalsreportable segmentsegment profit2021-07-01 → 2021-09-30¥19.0bn
jpcrp040300-q3r_E21183-000Pharmaceuticalsreportable segmentrevenue2021-01-01 → 2021-09-30¥721.0bn
jpcrp040300-q3r_E21183-000Pharmaceuticalsreportable segmentrevenue2021-07-01 → 2021-09-30¥248.5bn
jpcrp040300-q3r_E21183-000Pharmaceuticalsreportable segmentrevenue external2021-01-01 → 2021-09-30¥721.0bn
jpcrp040300-q3r_E21183-000Pharmaceuticalsreportable segmentrevenue external2021-07-01 → 2021-09-30¥248.5bn
jpcrp040300-q3r_E21183-000Pharmaceuticalsreportable segmentsegment profit2021-01-01 → 2021-09-30¥128.0bn
jpcrp040300-q3r_E21183-000Pharmaceuticalsreportable segmentsegment profit2021-07-01 → 2021-09-30¥34.5bn
—segment totalrevenue2021-01-01 → 2021-09-30¥1.14T
—segment totalrevenue2021-07-01 → 2021-09-30¥399.0bn
—segment totalrevenue external2021-01-01 → 2021-09-30¥1.11T
—segment totalrevenue external2021-07-01 → 2021-09-30¥388.6bn
—segment totalrevenue intersegment2021-01-01 → 2021-09-30¥28.5bn
—segment totalrevenue intersegment2021-07-01 → 2021-09-30¥10.4bn
—segment totalsegment profit2021-01-01 → 2021-09-30¥191.8bn
—segment totalsegment profit2021-07-01 → 2021-09-30¥58.7bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 835
ItemContextValueUnit
Total transactions with owners IFRSCurrentYTDDuration-55130000000JPY
Equity IFRSCurrentQuarterInstant_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember179953000000JPY
Equity IFRSCurrentQuarterInstant_EffectivePortionOfCashFlowHedgesIFRSMember-8000000JPY
Equity IFRSCurrentQuarterInstant_OtherComponentsOfEquityIFRSMember213227000000JPY
Equity IFRSCurrentQuarterInstant_EquityAttributableToOwnersOfParentIFRSMember2296927000000JPY
Equity IFRSCurrentQuarterInstant_NonControllingInterestsIFRSMember37493000000JPY
Equity IFRSCurrentQuarterInstant2334421000000JPY
Profit loss before tax IFRSPrior1YTDDuration166308000000JPY
Profit loss before tax IFRSCurrentYTDDuration145999000000JPY
Depreciation and amortization ope cf IFRSPrior1YTDDuration62301000000JPY
Depreciation and amortization ope cf IFRSCurrentYTDDuration69237000000JPY
Impairment losses reversal of impairment losses ope cf IFRSPrior1YTDDuration5051000000JPY
Impairment losses reversal of impairment losses ope cf IFRSCurrentYTDDuration30697000000JPY
Share of loss profit of investments accounted for using equity method ope cf IFRSPrior1YTDDuration-8644000000JPY
Share of loss profit of investments accounted for using equity method ope cf IFRSCurrentYTDDuration-3696000000JPY
Finance income ope cf IFRSPrior1YTDDuration-11056000000JPY
Finance income ope cf IFRSCurrentYTDDuration-35177000000JPY
Finance costs ope cf IFRSPrior1YTDDuration2878000000JPY
Finance costs ope cf IFRSCurrentYTDDuration4026000000JPY
Decrease increase in inventories ope cf IFRSPrior1YTDDuration3858000000JPY
Decrease increase in inventories ope cf IFRSCurrentYTDDuration-5840000000JPY
Decrease increase in trade and other receivables2 ope cf IFRSPrior1YTDDuration31025000000JPY
Decrease increase in trade and other receivables2 ope cf IFRSCurrentYTDDuration24469000000JPY
Increase decrease in trade and other payables2 ope cf IFRSPrior1YTDDuration-29304000000JPY
Increase decrease in trade and other payables2 ope cf IFRSCurrentYTDDuration-42164000000JPY
Other changes in working capital ope cf IFRSPrior1YTDDuration18448000000JPY
Other changes in working capital ope cf IFRSCurrentYTDDuration7526000000JPY
Subtotal ope cf IFRSPrior1YTDDuration240865000000JPY
Subtotal ope cf IFRSCurrentYTDDuration195078000000JPY
Interest and dividends received ope cf IFRSPrior1YTDDuration8269000000JPY
Interest and dividends received ope cf IFRSCurrentYTDDuration9370000000JPY
Interest paid ope cf IFRSPrior1YTDDuration-2044000000JPY
Interest paid ope cf IFRSCurrentYTDDuration-2108000000JPY
Income taxes refund paid ope cf IFRSPrior1YTDDuration-49880000000JPY
Income taxes refund paid ope cf IFRSCurrentYTDDuration-31268000000JPY
Net cash provided by used in operating activities IFRSPrior1YTDDuration197210000000JPY
Net cash provided by used in operating activities IFRSCurrentYTDDuration171071000000JPY
Proceeds from sale of property plant and equipment inv cf IFRSPrior1YTDDuration1672000000JPY
Proceeds from sale of property plant and equipment inv cf IFRSCurrentYTDDuration3362000000JPY
Purchase of property plant and equipment inv cf IFRSPrior1YTDDuration-36643000000JPY
Purchase of property plant and equipment inv cf IFRSCurrentYTDDuration-44900000000JPY
Purchase of intangible assets inv cf IFRSPrior1YTDDuration-12843000000JPY
Purchase of intangible assets inv cf IFRSCurrentYTDDuration-40596000000JPY
Proceeds from sale of investments inv cf IFRSPrior1YTDDuration17417000000JPY
Proceeds from sale of investments inv cf IFRSCurrentYTDDuration34223000000JPY
Purchase of investments inv cf IFRSPrior1YTDDuration-20802000000JPY
Purchase of investments inv cf IFRSCurrentYTDDuration-17972000000JPY
Proceeds from sale of subsidiaries inv cf IFRSPrior1YTDDuration－JPY
Proceeds from sale of subsidiaries inv cf IFRSCurrentYTDDuration8323000000JPY
Payments for acquisition of subsidiaries inv cf IFRSPrior1YTDDuration-8036000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 16 of 16 passed
balance sheet identityconsolidated 2021-12-31pass rounding
balance sheet identityconsolidated 2022-09-30pass
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2021-01-01/2021-09-30pass
statement vs summary · net income attributable to parentconsolidated 2021-07-01/2021-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-01-01/2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-07-01/2022-09-30pass
statement vs summary · operating cash flowconsolidated 2021-01-01/2021-09-30pass
statement vs summary · operating cash flowconsolidated 2022-01-01/2022-09-30pass
statement vs summary · revenueconsolidated 2021-01-01/2021-09-30pass
statement vs summary · revenueconsolidated 2021-07-01/2021-09-30pass
statement vs summary · revenueconsolidated 2022-01-01/2022-09-30pass
statement vs summary · revenueconsolidated 2022-07-01/2022-09-30pass
statement vs summary · total assetsconsolidated 2021-12-31pass
statement vs summary · total assetsconsolidated 2022-09-30pass